Years in the making...@freenome achieved 94% Sens and 94% Spec in Stage I and II CRC Screening from Blood in a fully prospective cohort. Final study for FDA approval begins this year! Thanks to everyone’s monumental efforts to achieve this milestone! bwnews.pr/2NSoZ82
Gabriel Otte
532 posts
Co-founder, @DinariGlobal (dinari.com), Partner at Healthcare Co-op • Founder of @Freenome - Any comments are my individual opinions.
- Accurate early detection blood test for cancer is going to be one of the most fundamental breakthroughs of our generation. Within a few years, we will detect cancer at the earliest points when it can be cured: cnbc.com/amp/2020/02/01… @freenome @MichaelPellini @AmericanCancer
- How many ML/AI entrepreneurs have an investor that can explain AI better than them? Mine can. @vijaypande @a16z
- Dinari Financial Network will allow dShares to live on every chain and every country without sacrificing liquidity: coindesk.com/business/2025/…
- It was a pleasure to speak with @sbarnettARK! Thank you for the thoughtful discussion around the challenges of making early detection of cancer available to everyone!Check out my newest podcast with @GabeOtte, co-founder and CEO of @freenome, one of the most exciting companies tackling earlier cancer detection. I'm eager for you all to listen and engage with us more on one of the most important topics in healthcare. ark-invest.com/podcast/ep87-e…
- Really excited for our future with @BitGo! I look forward to sharing more about what @mikebelshe and we have been cooking up!
- Over the last couple of weeks, I've gotten reach outs from fellow founders asking for tips on how to raise money with an air of "tell us why it's so easy for you." It's never easy and I don't like that we live in a society where we pretend that it ever is. So here's some truths:
- Excited to share the news! “Freenome Raises $65M in Series A from Andreessen Horowitz, GV and others”
- Our paper on using DNA from immune cells to predict TF binding for early detection of cancer is out in @NatureComms today! This shows how using immune sigs can overcome low sensitivity that tumor sigs have. Congrats to the @freenome and the CD lab teams!
- We are excited to take this next step to bring us closer to a simple blood test that will detect colorectal cancer at the earliest points possible when it can be cured. @freenome.@freenome is conducting the first clinical validation study of an AI+genomics based blood test. businesswire.com/news/home/2018…
- As we launch our 14,000-patients prospective study for validation of our cancer blood test, I’m honored to be working with @AmerCancerCEO Gary Reedy and Bill Quirk (from Piper Sandler) as our CFO!
- 1) I generally don't like speaking on entrenched topics (media vs. founders) but seeing the nasty interactions that seem to only be getting worse, I feel that I must offer a perhaps unpopular opinion:






